The future of multiple sclerosis treatments
Introduction. There are not many conditions in which the last few decades have brought such a major change in the landscape of treatments as is the case of multiple sclerosis (MS). A number of disease modifying treatments (DMTs) are presently available for the treatment of the inflammatory phase of...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Expert Reviews
2016
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/37718/ |
| _version_ | 1848795518630625280 |
|---|---|
| author | Coclitu, Catalina Constantinescu, Cris S. Tanasescu, Radu |
| author_facet | Coclitu, Catalina Constantinescu, Cris S. Tanasescu, Radu |
| author_sort | Coclitu, Catalina |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Introduction. There are not many conditions in which the last few decades have brought such a major change in the landscape of treatments as is the case of multiple sclerosis (MS). A number of disease modifying treatments (DMTs) are presently available for the treatment of the inflammatory phase of this disabling disease; however, the need for treating neurodegeneration and halting the progression of disability is still unmet.
Areas covered: In this paper we review the available information on existing and emerging DMTs and we discuss their place within the context of different treatment strategies in MS.
Expert Commentary: The future of MS treatments should include the development of new treatment strategies tackling disease progression, together with a better understanding of the side-effects and the best sequential strategy of implementation of available and emerging drugs. |
| first_indexed | 2025-11-14T19:33:22Z |
| format | Article |
| id | nottingham-37718 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T19:33:22Z |
| publishDate | 2016 |
| publisher | Expert Reviews |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-377182020-05-04T18:16:05Z https://eprints.nottingham.ac.uk/37718/ The future of multiple sclerosis treatments Coclitu, Catalina Constantinescu, Cris S. Tanasescu, Radu Introduction. There are not many conditions in which the last few decades have brought such a major change in the landscape of treatments as is the case of multiple sclerosis (MS). A number of disease modifying treatments (DMTs) are presently available for the treatment of the inflammatory phase of this disabling disease; however, the need for treating neurodegeneration and halting the progression of disability is still unmet. Areas covered: In this paper we review the available information on existing and emerging DMTs and we discuss their place within the context of different treatment strategies in MS. Expert Commentary: The future of MS treatments should include the development of new treatment strategies tackling disease progression, together with a better understanding of the side-effects and the best sequential strategy of implementation of available and emerging drugs. Expert Reviews 2016-10-21 Article PeerReviewed Coclitu, Catalina, Constantinescu, Cris S. and Tanasescu, Radu (2016) The future of multiple sclerosis treatments. Expert Review of Neurotherapeutics, 16 (12). ISSN 1744-8360 Multiple sclerosis Immunomodulation Monoclonal antibodies Remyelination Repurposing http://www.tandfonline.com/doi/abs/10.1080/14737175.2016.1243056?journalCode=iern20 doi:10.1080/14737175.2016.1243056 doi:10.1080/14737175.2016.1243056 |
| spellingShingle | Multiple sclerosis Immunomodulation Monoclonal antibodies Remyelination Repurposing Coclitu, Catalina Constantinescu, Cris S. Tanasescu, Radu The future of multiple sclerosis treatments |
| title | The future of multiple sclerosis treatments |
| title_full | The future of multiple sclerosis treatments |
| title_fullStr | The future of multiple sclerosis treatments |
| title_full_unstemmed | The future of multiple sclerosis treatments |
| title_short | The future of multiple sclerosis treatments |
| title_sort | future of multiple sclerosis treatments |
| topic | Multiple sclerosis Immunomodulation Monoclonal antibodies Remyelination Repurposing |
| url | https://eprints.nottingham.ac.uk/37718/ https://eprints.nottingham.ac.uk/37718/ https://eprints.nottingham.ac.uk/37718/ |